À¯ÀüÀÚ ÇÕ¼º ½ÃÀå : Á¦Ç°, ¹æ¹ý, À¯ÀüÀÚ À¯Çü, ¿ëµµ, ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Global Forecast 2025-2030
»óǰÄÚµå : 1600874
¸®¼­Ä¡»ç : 360iResearch Private Limited
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 186 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,939 £Ü 5,699,000
PDF, Excel & 1 Year Online Access (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 4,249 £Ü 6,147,000
PDF, Excel & 1 Year Online Access (2-5 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿Àϱâ¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 5,759 £Ü 8,332,000
PDF, Excel & 1 Year Online Access (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ Áö¿ª »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 6,969 £Ü 10,083,000
PDF, Excel & 1 Year Online Access (Enterprise User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯ÀüÀÚ ÇÕ¼º ½ÃÀåÀº 2023³â¿¡ 42¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 46¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 10.82%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 87¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯ÀüÀÚ ÇÕ¼ºÀ̶õ À¯ÀüÀÚ ¼­¿­À» óÀ½ºÎÅÍ È¿¼ÒÀû ¶Ç´Â È­ÇÐÀûÀ¸·Î Á¶¸³ÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ÇÕ¼º »ý¹°Çп¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ¿¬±¸ÀÚµéÀº ´Ù¾çÇÑ ¸ñÀûÀ» À§ÇØ Æ¯Á¤ DNA ¼­¿­À» »ý¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ±× Çʿ伺Àº ¿øÇÏ´Â »ý¹°ÇÐÀû Ư¼ºÀ» °¡Áø ÇÕ¼º À¯ÀüÀÚ¸¦ ¾ò´Â °úÁ¤À» ±âÁ¸ÀÇ º¹Á¦ ¹æ¹ýº¸´Ù ÈξÀ ´ÜÃàÇÒ ¼ö ÀÖ´Ù´Â µ¥ ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ÇÕ¼ºÀÇ ¿ëµµ´Â Á¦¾à, ³ó¾÷, ¹é½Å °³¹ß, »ê¾÷ »ý¸í°øÇÐ µî ¿©·¯ ºÐ¾ß¿¡ °ÉÃÄ ÀÖÀ¸¸ç, ÃÖÁ¾ »ç¿ë »ê¾÷Àº Á¦Ç° °³¹ß, ¿¬±¸, Ä¡·á È¿°ú¿¡ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 42¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â[2024] 46¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â[2030] 87¾ï ´Þ·¯
CAGR(%) 10.82%

½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é À¯ÀüÀÚ ÇÕ¼ºÀº ¸ÂÃã ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, À¯Àü°øÇÐÀÇ ¹ßÀü, ¿¬±¸°³¹ß Ȱµ¿ÀÇ È°¼ºÈ­·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀå ±Ëµµ¸¦ ±×¸®°í ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ÇÕ¼ºÀÇ ºñ¿ë °¨¼Ò¿Í ÇÔ²² ÇÕ¼º »ý¹°ÇÐ ¿ëµµ Áõ°¡´Â ÀÌ·¯ÇÑ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª À±¸®Àû ³í¶õ, º¹ÀâÇÑ ±ÔÁ¦, ÇÕ¼º À¯ÀüÀÚÀÇ ¾Ç¿ë °¡´É¼º µîÀÇ ¹®Á¦µµ ¿©ÀüÈ÷ ³²¾Æ ÀÖ½À´Ï´Ù. °¡Àå Å« ÇѰè´Â ±ä À¯ÀüÀÚ³ª °íµµ·Î º¹ÀâÇÑ À¯ÀüÀÚ¸¦ Á¶¸³ÇÏ´Â µ¥ ÀÖÀ¸¸ç, ±â¼úÀû º¹À⼺À̸ç, ÀÌ´Â ºñ¿ë°ú ¸®µå ŸÀÓ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

ƯÈ÷ »õ·Î¿î Ä¡·áÁ¦ ¹× ¹é½Å °³¹ß, °¡¹³¿¡ °­ÇÑ ÀÛ¹° Á¦ÀÛ, ¹ÙÀÌ¿À¿¬·á »ý»ê °­È­ µî ½ÃÀå °³Ã´ÀÇ ±âȸ´Â ¹«±Ã¹«ÁøÇÕ´Ï´Ù. ±â¾÷Àº ÇÕ¼º Á¤È®µµ¸¦ ³ôÀÌ°í ¿À·ùÀ²À» ³·Ãß´Â ±â¼ú¿¡ ÅõÀÚÇÔÀ¸·Î½á À̸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿¬±¸ ±â°ü°úÀÇ Á¦ÈÞ¸¦ ÅëÇØ CRISPR À¯ÀüÀÚ ÆíÁý ½Ã½ºÅÛ°ú °°Àº ¿ëµµÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀÇ ÁÖ¿ä ºÐ¾ß´Â ¼­¿­ ¼³°è¸¦ À§ÇÑ º¸´Ù Á¤±³ÇÑ ¾Ë°í¸®Áò °³¹ß, ¿°±â½Ö ÇÕ¼º Á¤È®µµ Çâ»ó, ´õ Å« À¯ÀüÀÚ ¼­¿­À» ó¸®ÇÒ ¼ö ÀÖ´Â ÇÕ¼º °øÁ¤ÀÇ È®À强 °­È­ µîÀÔ´Ï´Ù. ¸ÂÃãÇü ¹ÌÃæÁ· ¼ö¿ä¿¡ ´ëÀÀÇϰí, ±âÁ¸ »ý¸í°øÇÐ ½ÃÀå ¿Ü ½ÃÀåÀ¸·Î ¼­ºñ½º Á¦°øÀ» È®´ëÇÔÀ¸·Î½á »ç¾÷ ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ °æÀï ¿ìÀ§¸¦ Áö¼ÓÇϱâ À§ÇØ ±â¾÷Àº °øÁ¤ È¿À²À» °³¼±Çϰí ÀÀ¿ë °¡´É¼ºÀ» È®´ëÇÏ´Â µ¥ ÁýÁßÇØ¾ß Çϸç, µ¿½Ã¿¡ À¯ÀüÀÚ ÇÕ¼º°ú °ü·ÃµÈ »çȸÀû, À±¸®Àû ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ ±ÔÁ¦ »óȲÀ» ±Øº¹ÇØ¾ß ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â À¯ÀüÀÚ ÇÕ¼º ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

À¯ÀüÀÚ ÇÕ¼º ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Portre's Five Forces: À¯ÀüÀÚ ÇÕ¼º ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« Åø

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â À¯ÀüÀÚ ÇÕ¼º ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : À¯ÀüÀÚ ÇÕ¼º ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº À¯ÀüÀÚ ÇÕ¼º ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® À¯ÀüÀÚ ÇÕ¼º ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

À¯ÀüÀÚ ÇÕ¼º ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º À¯ÀüÀÚ ÇÕ¼º ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â À¯ÀüÀÚ ÇÕ¼º ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀº º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ¾÷°è ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æ¿¡ ´ëÇÑ »ó¼¼ÇÑ °ËÅä.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

Á¦6Àå À¯ÀüÀÚ ÇÕ¼º ½ÃÀå : Á¦Ç°º°

Á¦7Àå À¯ÀüÀÚ ÇÕ¼º ½ÃÀå : ¹æ¹ýº°

Á¦8Àå À¯ÀüÀÚ ÇÕ¼º ½ÃÀå : À¯ÀüÀÚ À¯Çüº°

Á¦9Àå À¯ÀüÀÚ ÇÕ¼º ½ÃÀå : ¿ëµµº°

Á¦10Àå À¯ÀüÀÚ ÇÕ¼º ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ À¯ÀüÀÚ ÇÕ¼º ½ÃÀå

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯ÀüÀÚ ÇÕ¼º ½ÃÀå

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« À¯ÀüÀÚ ÇÕ¼º ½ÃÀå

Á¦14Àå °æÀï ±¸µµ

±â¾÷ ¸®½ºÆ®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Gene Synthesis Market was valued at USD 4.24 billion in 2023, expected to reach USD 4.68 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 8.70 billion by 2030.

Gene synthesis refers to the enzymatic or chemical assembly of gene sequences from scratch. It plays a pivotal role in synthetic biology, enabling researchers to create specific DNA sequences for various purposes. Its necessity arises from its ability to expedite the process of obtaining synthetic genes with desired biological properties, which is significantly faster than traditional cloning methods. Applications of gene synthesis span multiple domains, including pharmaceuticals, agriculture, vaccine development, and industrial biotechnology, with end-use industries leveraging it for product development, research, and therapeutic efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 4.24 billion
Estimated Year [2024] USD 4.68 billion
Forecast Year [2030] USD 8.70 billion
CAGR (%) 10.82%

Market insights indicate a robust growth trajectory for gene synthesis driven by increasing demand for personalized medicine, advancements in genetic engineering, and heightened R&D activities. The rise in synthetic biology applications, alongside decreasing costs of gene synthesis, further fuels this growth. However, challenges persist, such as ethical controversies, regulatory complexities, and potential misuse of synthetic genes. A major limitation is the technical complexity involved in assembling long or highly complex genes, which can affect costs and lead time.

Opportunities in the market are vast, particularly in the development of new therapeutic drugs and vaccines, crafting drought-resistant crops, and enhancing biofuel production. Companies can capitalize on these by investing in technologies that improve synthesis accuracy and reduce error rates. Additionally, partnerships with research institutions could expedite innovations in applications like CRISPR gene-editing systems.

Key areas for innovation include developing more sophisticated algorithms for sequence design, improving base-pair synthesis accuracy, and enhancing the scalability of synthesis processes to handle larger genetic sequences. Business growth can be further accelerated by addressing the unmet needs in customizable gene synthesis and expanding service offerings to non-traditional biotech markets. Hence, for sustained competitive advantage, companies should focus on improving process efficiencies and expanding application potential, all while navigating the regulatory landscape to address societal and ethical concerns associated with gene synthesis.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Synthesis Market

The Gene Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Porter's Five Forces: A Strategic Tool for Navigating the Gene Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Synthesis Market

A detailed market share analysis in the Gene Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Biomatik Corporation, Biotech Desk Pvt. Ltd., Twist Bioscience Corporation, ProteoGenix SAS, Creative Biogene, Biotage AB, General Biosystems, Inc., Ansa Biotechnologies, Inc., ProMab Biotechnologies, Inc., Barcode Biosciences Private Limited, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Eurofins Scientific SE, Telesis Bio Inc., Macrogen, Inc., Elegen Corp., Gene Universal, Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Synbio Technologies LLC, Danaher Corporation, Constructive Bio Ltd, GenCefe Biotech Limited, NZYTech, Lda., Evonetix Ltd., OriGene Technologies, Inc., BGI Genomics by BGI Group, Boster Biological Technology, Bioneer Corporation, Brooks Automation Inc., QIAGEN N.V., Agilent Technologies, Inc., Merck KGaA, AstraZeneca PLC, Ginkgo Bioworks Holdings, Inc., GenScript Biotech Corporation, Camena Bioscience, Azenta, Inc., BioCat GmbH by AddLife AB, and Applied Biological Materials Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Gene Synthesis Market, by Product

7. Gene Synthesis Market, by Method

8. Gene Synthesis Market, by Gene Type

9. Gene Synthesis Market, by Application

10. Gene Synthesis Market, by End-use

11. Americas Gene Synthesis Market

12. Asia-Pacific Gene Synthesis Market

13. Europe, Middle East & Africa Gene Synthesis Market

14. Competitive Landscape

Companies Mentioned

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â